Skip to main content

Closed

PALI: Palisade Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-20.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-3311.8×

Current ratio23.71×

Palisade Bio, Inc.

PALINASDAQ Capital Market·USD·Closed

Palisade Bio, Inc.

PALINASDAQ·USD·Closed

$1.90

−3.32%

$1.90

−$0.06 (3.32%)

52W Range

59thpctl

Volume

0.54×avg

Mkt Cap

328.93MUSD

P/E

-1.8TTM

Div Yield

–ann

52W Range

59thpctl

Volume

0.54×avg

Market Cap

328.93MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings